Pharmaceutical Outsourcing covers news of importance to the contract services segment of the pharmaceutical industry.
Collected from the most trusted on-line resources, these news stories are chosen and published here based on their relevance to the pharmaceutical industry.
Topics of interest typically include: mergers and acquisitions, service additions, new capabilities, personnel changes, news from the FDA and other international regulatory and standard-setting agencies, and new outsourcing contracts and deals.
If you are looking to stay up-to-date with the news in your industry, this resource is vital for your industry knowledge.
Blue Tech Industries has signed a Master Service Agreement with a new customer to manufacture the customer’s amniotic membrane platform for the next two years.
read more
BioStem Life Sciences has received it’s ISBT 128 Registration from the ICCBBA.
read more
BioStem Life Sciences announced the buildout of a brand new R&D lab.
read more
BioSpring announced the development of a pharmaceutical facility dedicated to nucleic acid-based therapeutics in Offenbach. This expansion marks a significant milestone for both the company and Germany’s rapidly growing biotech sector.
read more
Carolyn Finkle, Vice President, Global Regulatory Consulting at Catalent Pharma Solutions will present a webinar on “Biosimilars: Current Regulatory Environment and Development and Manufacturing Considerations” for the Pharmaceutical Education and ...
read more
Bioscript, a full-service pharmaceutical communications company, announced two strategic acquisitions that strengthen and extend its integrated service offering. Fortis Pharma Consulting, a London-based specialist in medical affairs services, brings ...
read more
Bios Health Group entered into the Life Science market to help biotech entrepreneurs and executives take their innovative ideas to the next level.
read more
Wednesday, March 06, 2013
Sigma-Aldrich® Corporation today announced that BioReliance® (http://www.bioreliance.com), the biologics and early development services business under SAFC® (www.safcglobal.com), has signed an agreement to acquire the colonies required for the Big ...
read more
BioReference Laboratories, an OPKO Health company, is now accepting specimens for a new multiplex COVID-19 and influenza test.
read more
BioreclamationIVT has signed a new distribution partnership agreement with Cellaria, LLC.
read more
BIOPHYTIS, a biotechnology company specializing in the development of drug candidates to treat age-related diseases, has announced the contracting of SGS Life Science Services to conduct the MACA-PK clinical study of its drug candidate Macuneos in ...
read more
BioPharmaSpec announced it is expanding its in-house capabilities for characterizing higher order protein structure.
read more
BioPharma Services announced it has successfully completed three inspections this month by the FDA, with concurrent audits at both research centers in Toronto, Canada, and Columbia, Missouri.
read more
Monday, September 25, 2017
BioPharma Services has successfully completed its first year of collaboration with the CDER, a division of the FDA.
read more
BioPharma Services Inc. has announced that its Toronto-based clinical and bioanalytical site for Phase I/IIa clinical trials and bioequivalence studies has successfully completed an audit by the U.S. Food and Drug Administration (FDA).
read more